Dow Up 0.76% Nasdaq Up 0.69%

AbbVie Inc. (ABBV)

-NYSE
60.29 Up 0.77(1.29%) Oct 24, 4:02PM EDT
|After Hours : 60.28 Down 0.01 (0.02%) Oct 24, 6:31PM EDT
Prev Close:59.52
Open:59.34
Bid:59.99 x 200
Ask:60.29 x 300
1y Target Est:64.62
Beta:1.928
Next Earnings Date:31-Oct-14ABBV Earnings announcement
Day's Range:59.34 - 60.41
52wk Range:45.50 - 60.41
Volume:10,391,657
Avg Vol (3m):14,224,100
Market Cap:95.96B
P/E (ttm):23.37
EPS (ttm):2.58
Div & Yield:1.96 (3.40%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
ABBVUp 1.29%95.96B
MRKUp 1.73%166.18B
NVSUp 1.02%218.72B
PFEUp 1.78%184.58B

Key Statistics

Forward P/E (1 yr):14.85
P/S (ttm):4.92
Ex-Dividend Date:13-Jan-15

Analysts

Annual EPS Est (Dec-14) :3.16
Quarterly EPS Est (Sep-14) :0.77
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. Its products include adult and pediatric pharmaceuticals, such as HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune d... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback